A Mobile Health (mHealth) Strategy for Improving Blood Pressure Control Among Adult Hypertensive African Americans
Launched by UNIVERSITY OF CHICAGO · Oct 5, 2023
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring a new mobile health application called USeeBP, which aims to help African American adults better manage their high blood pressure, also known as hypertension. The study will be conducted as part of an existing program at UChicago Medicine that monitors patients remotely. The goal is to see if adding the USeeBP app can improve blood pressure control for those who have struggled with it in the past.
To participate, you need to be an African American adult aged 18 to 65 with a history of high blood pressure. You should also have access to a smartphone and be willing to use a wireless blood pressure cuff. Participants will receive support to download and use the USeeBP app, which will help track and manage their blood pressure. This trial is currently recruiting, so if you meet the eligibility criteria and are interested in improving your blood pressure management, this could be a great opportunity to get involved.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • African American
- • Ages 18 to 65 years old
- • Able to demonstrate English reading literacy of at least 8th grade level \[Rapid Estimate of Adult Literacy in Medicine, Revised (REALM-R) score ≥ 6\]
- • Prior hypertension (HTN) diagnosis
- • Clinically measured SBP ≥ 160 mmHg recorded during at least 2 of last 4 encounters within past 2 years
- • UCM-RPM Hypertension Management Program current or eligible participant
- • Access to an Android or Apple iOS smartphone and its corresponding health app
- • Access to an active data plan or home Wi-Fi
- • Willing to use wireless electronic blood pressure cuff (eCuff)
- • Has access to EPIC myChart mobile app or is willing to establish myChart account and download app
- • Willing to download USeeBP study app to phone
- • Willing to download and use USeeBP app with staff assistance
- Exclusion Criteria:
- • Hypertension is managed by a specialist (specialist prescribes the anti-hypertensive therapies)
- • Baseline blood pressure greater than 180/110
- • Prior enrollment in the study
- • Known pregnancy
- • Prisoners
- • Active opioid dependency
- • Homelessness
- • Psychiatric hospitalization in the last year
- • Serious existing medical conditions that may make BP control difficult or necessitate frequent hospitalization (cirrhosis or hepatic failure, stage IV or V chronic kidney disease, interstitial nephritis, pulmonary arterial hypertension, right heart failure, history of dementia or neurocognitive disability, advanced heart failure, organ transplant, immunosuppressive therapy, active cancer treatment, patients on hospice care), stroke or myocardial infarction in past 90 days, severe aortic stenosis
- • Hospital admission for primary diagnosis of hypertensive emergency, hypertensive urgency, or uncontrolled hypertension in the past 90 days
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
David G. Beiser, MD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported